Mohamed Khaled Diab

Dr. Mohamed Khaled Diab

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in RSC Advances
Verified
Journal Article
Open access
MNMohamed S. Nafie
Mohamed S. Nafie
ISIhab Shawish
Ihab Shawish
Sherif Ashraf FahmySherif Ashraf Fahmy
Sherif Ashraf Fahmy
MDMohamed Khaled Diab
Mohamed Khaled Diab
MAMariam M. Abdelfattah
Mariam M. Abdelfattah
Assem BarakatAssem Barakat
Assem Barakat
This review covers the recent developments of synthetic routes of derivatization and anticancer activities of halogenated spirooxindoles scaffolds during 2020–2025, highlighting the molecular targets.

19 May 2024 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
MDMohamed Khaled Diab
Mohamed Khaled Diab
HMHala Mohamed Mead
Hala Mohamed Mead
MKMohamad M. Ahmad Khedr
Mohamad M. Ahmad Khedr
Abdelghafar M. Abu-ElsaoudAbdelghafar M. Abu-Elsaoud
Abdelghafar M. Abu-Elsaoud
SESahar Ahmed El-Shatoury
Sahar Ahmed El-Shatoury

1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
MNMohamed S. Nafie
Mohamed S. Nafie
Abdelghafar M. Abu-ElsaoudAbdelghafar M. Abu-Elsaoud
Abdelghafar M. Abu-Elsaoud
MDMohamed Khaled Diab
Mohamed Khaled Diab
Computational metabolomics will be established in drug discovery and research on complex biological networks. This field of research enhances the detection of metabolic biomarkers and the prediction of molecular interactions by combining multiscale analysis with in silico and molecular docking methods. These include nuclear magnetic resonance, mass spectrometry, and innovative bioinformatics, which enable the accurate generation and characterization of metabolomes. Molecular docking is a crucial tool for simulating the interaction between ligands and receptors, thereby facilitating the identification of potential therapeutics. It also discusses the potential of metabolomics to inform drug modes of action, from pharmacokinetics to forecasting toxicity, thereby streamlining drug development pipelines. We highlight applications in anticancer, antimicrobial, and antiviral drug discovery and explain how these computational models can accelerate target validation and enhance the accuracy of therapeutic strategies. In addition, this review addresses the current challenges and future directions for computational techniques in conjunction with experimental data to advance personalized medicine. In conclusion, this review aims to highlight the prospective approaches of computational metabolomics and molecular docking that identify evolutionary adaptive metabolisms of multiscale biological systems through their synergistic utilization to overcome the key hurdles involved in both drug discovery and metabolomic research.

15 May 2023 in AMB Express
Verified
Journal Article
Open access
PDF file
MDMohamed Khaled Diab
Mohamed Khaled Diab
HMHala M. Mead
Hala M. Mead
MKMohamad A. Khedr
Mohamad A. Khedr
MNMohamed S. Nafie
Mohamed S. Nafie
Abdelghafar M. Abu-ElsaoudAbdelghafar M. Abu-Elsaoud
Abdelghafar M. Abu-Elsaoud
SESahar A. El-Shatoury
Sahar A. El-Shatoury
Insecticide resistance in agricultural pests has prompted the need to discover novel compounds with new modes of action. We investigated the potency of secondary metabolites from seventy endophytic actinobacteria against laboratory and field strains of Spodoptera littoralis (fourth instar), comparable to the bioinsecticide spinetoram (Radiant SC 12%). Endophytes from Artemisia herba-alba and A. judaica were highly effective. Chemical profiling of the most potent metabolite of the strain Streptomyces sp. ES2 was investigated using LC-QTOF-MS-MS technique, and the activity was validated through molecular docking studies. Metabolic extracts from actinobacteria belonging to Streptomyces, Nocardioides, and Pseudonocardia showed immediate and latent death to the Spodoptera littoralis fourth instar larvae. The metabolite from strain ES2 has shown the most promising and significant histopathological and inhibitory effects on the fourth instar larvae. ES2 metabolite caused lesions in the body wall cuticle, indicating a different mode of action than that of Radiant. Chemical profiling of ES2 showed the presence of cyromazine (molt inhibitor), 4-nitrophenol, and diazinon as key constituents. In conclusion, these findings suggest that secondary metabolites from endophytic actinobacteria inhabiting wild medicinal plants can be a sustainable source for promising natural biocontrol agents. This is the first illustration of the insecticidal activity of Artemisia spp. microbiome, and natural cyromazine synthesis by actinobacteria.

27 July 2025 in Phytochemistry Reviews
Verified
Journal Article
Open access
PDF file
MDMohamed Khaled Diab
Mohamed Khaled Diab
Abdelghafar M. Abu-ElsaoudAbdelghafar M. Abu-Elsaoud
Abdelghafar M. Abu-Elsaoud
MSMohamed G. Salama
Mohamed G. Salama
EGEman M. Ghareeb
Eman M. Ghareeb
Artemisia herba-alba and Artemisia judaica are two pharmacologically important species of the Artemisia genus, which are characterized by their varied phytochemical composition and a wide range of bioactivities. Traditionally, these species are well known in ethnomedicine and have aroused interest for applications in modern pharmacology, sustainable agriculture, and environmental management. Varieties of therapeutic properties, including antimicrobial, antioxidant, anti-inflammatory, anticancer, and pesticidal properties, have been associated with phytochemicals such as flavonoids, terpenoids, essential oils, and phenolic acids. These genera not only fight great health disorders such as neurodegenerative diseases, cancer, or diabetes, but they also can contribute with green alternatives for agriculture (biopesticides and herbicide solutions), addressing a global market with high demand for sustainability. Advances in extraction and characterization methodologies with insights from genomics and metabolomics have increased the knowledge base of their bioactive profiles, and their potential has been expanded to other areas such as antiviral applications and phytoremediation but requires further validation. However, the effects of standardization, manufacturing scalability, and regulatory frameworks have not yet been fully recognized or handled, requiring further multidisciplinary research and innovation to address these challenges. In this review, we emphasize the distinctive value of A. herba-alba and A. judaica as natural resources against a series of current health, agricultural, and environmental issues and highlight their bioactivities and potential applications, including proposals for future applications.

6 February 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MDMohamed Khaled Diab
Mohamed Khaled Diab
HMHala Mohamed Mead
Hala Mohamed Mead
MKMohamad Ahmad Khedr
Mohamad Ahmad Khedr
MNMohamed S. Nafie
Mohamed S. Nafie
Abdelghafar M. Abu-ElsaoudAbdelghafar M. Abu-Elsaoud
Abdelghafar M. Abu-Elsaoud
SESahar Ahmed El-Shatoury
Sahar Ahmed El-Shatoury
The polyphagous pest, Spodoptera littoralis (Boisduval), poses a significant global economic threat by gregariously feeding on over a hundred plant species, causing substantial agricultural losses. Addressing this challenge requires ongoing research to identify environmentally safe control agents. This study aimed to elucidate the insecticidal activity of the metabolite (ES2) from a promising endophytic actinobacterium strain, Streptomyces sp. ES2 EMCC2291. We assessed the activity of ES2 against the eggs and fourth-instar larvae of S. littoralis through spectrophotometric measurements of total soluble protein, α- and β-esterases, polyphenol oxidase (PPO), and catalase enzyme (CAT). The assessments were compared to commercial Biosad® 22.8% SC. Untargeted metabolomics using LC-QTOF-MS/MS identified 83 metabolic compounds as chemical constituents of ES2. The median lethal concentration (LC50) of ES2 (165 mg/mL) for treated Spodoptera littoralis eggs showed significant differences in polyphenol oxidase and catalase enzymatic activities, while the LC50 of ES2 (695 mg/mL) for treated S. littoralis fourth instar larvae showed lower significance in α- and β-esterase activities. Molecular docking of ES2 identified seven potent biocidal compounds, showing strong affinity to PPO and catalase CAT proteins in S. littoralis eggs while displaying limited binding to alpha and beta esterase proteins in the larvae. The results contribute to the understanding of ES2 as a promising alternative biopesticide, providing insights for future research and innovative applications in sustainable pest management strategies.